Cargando…
A genetic variant in the LDLR promoter is responsible for part of the LDL-cholesterol variability in primary hypercholesterolemia
BACKGROUND: GWAS have consistently revealed that LDLR locus variability influences LDL-cholesterol in general population. Severe LDLR mutations are responsible for familial hypercholesterolemia (FH). However, most primary hypercholesterolemias are polygenic diseases. Although Cis-regulatory regions...
Autores principales: | De Castro-Orós, Isabel, Pérez-López, Javier, Mateo-Gallego, Rocio, Rebollar, Soraya, Ledesma, Marta, León, Montserrat, Cofán, Montserrat, Casasnovas, Jose A, Ros, Emilio, Rodríguez-Rey, Jose C, Civeira, Fernando, Pocoví, Miguel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4021749/ https://www.ncbi.nlm.nih.gov/pubmed/24708769 http://dx.doi.org/10.1186/1755-8794-7-17 |
Ejemplares similares
-
The genetic basis of familial hypercholesterolemia: inheritance, linkage, and mutations
por: De Castro-Orós, Isabel, et al.
Publicado: (2010) -
Effect of LDL cholesterol, statins and presence of mutations on the prevalence of type 2 diabetes in heterozygous familial hypercholesterolemia
por: Climent, Elisenda, et al.
Publicado: (2017) -
Association between non-cholesterol sterol concentrations and Achilles tendon thickness in patients with genetic familial hypercholesterolemia
por: Baila-Rueda, Lucía, et al.
Publicado: (2018) -
Interplay of Walnut Consumption, Changes in Circulating miRNAs and Reduction in LDL-Cholesterol in Elders
por: Gil-Zamorano, Judit, et al.
Publicado: (2022) -
Genetic Variants of LDLR and PCSK9 Associated with Variations in Response to Antihypercholesterolemic Effects of Armolipid Plus with Berberine
por: De Castro-Orós, Isabel, et al.
Publicado: (2016)